Accessibility navigation


Technology transfer in the interwar U.S. pharmaceuticals sector: the case of E. Merck of Darmstadt and Merck & Co., Rahway NJ

Godley, A., Joseph, M. and Hughes, D. L. (2019) Technology transfer in the interwar U.S. pharmaceuticals sector: the case of E. Merck of Darmstadt and Merck & Co., Rahway NJ. Enterprise and Society. ISSN 1467-2235

[img]
Preview
Text - Accepted Version
· Please see our End User Agreement before downloading.

840kB

It is advisable to refer to the publisher's version if you intend to cite from this work. See Guidance on citing.

To link to this item DOI: 10.1017/eso.2018.97

Abstract/Summary

This is a case study of the U.S. pharmaceuticals producer, Merck & Co. By 1940 this was one of the leading pharmaceutical producers in the United States, and went on to become one of the global industry leaders after the second world war. It was founded in 1891 as the U.S. subsidiary of a much larger German pharmaceuticals company, E. Merck of Darmstadt. The existing understanding of Merck & Co’s history emphasises how it was reacquired by the American branch of the Merck family after wartime sequestration, and that from then onwards it pursued a path of development separate from its former parent. This article revisits that history of the company and shows how the two Merck’s began to co operate and share technology and manufacturing know-how during the 1930s, something which was particularly to the advantage of Merck & Co.

Item Type:Article
Refereed:Yes
Divisions:Henley Business School > Leadership, Organisations and Behaviour
ID Code:81625
Publisher:Oxford University Press

Downloads

Downloads per month over past year

University Staff: Request a correction | Centaur Editors: Update this record

Page navigation